Chardan Healthcare Acquisition 2 Corp. announced that it has entered into subscription agreements with certain investors for a private placement of 3,000,000 shares of par value, $0.0001 at a price of $10 per share for gross proceeds of $30,000,000 on March 22, 2021. The transaction will involve participation from a group of premier investors including the sponsor, returning investor, Chardan Investments 2, LLC, other investors including, Chardan Healthcare Investments, an affiliate of Chardan Capital Markets LLC, Investment Arm, RTW Investments, LP, Citadel Multi-Strategy Equities Master Fund Ltd., a fund managed by Citadel Advisors LLC, Affinity Asset Advisors, LLC, Altium Capital Management LP, Ikarian Capital, LLC, Sio Capital Management, LLC, South Ocean Capital Management Llc, Acorn Bioventures, Longview Ventures and Innogest Capital, a fund managed by Innogest SGR S.p.A. A portion of the shares to be issued and sold in the transaction may be issued to certain Investors in the form of pre-funded warrants to purchase shares, at an initial purchase price of $9.99 per share.

The pre-funded warrants will be immediately exercisable at an exercise price of $0.01, subject to a 9.99% beneficial ownership limitation and will be exercisable indefinitely. The closing of the transaction is contingent upon, among other things, the substantially concurrent consummation of the Business Combination. The shares are subject to transfer restrictions.